Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months. Amid the continued...
French patient associations have warned that medical cannabis patients could soon face a disruption in treatment.
In a report from November 2023, France’s Directorate General of Health (DGS) recommended the roll out of a temporary regulatory framework.
The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
More details of how France’s long-awaited medical cannabis generalisation will look have been published.
The government has confirmed that access to medical cannabis treatment will continue for thousands of patients.
The health minister has confirmed that the country's medical cannabis experiment will continue.
Your round-up of the latest cannabis news
Reports suggest the Macron government will not support general legalisation when the medical cannabis experiment ends in 2024.
Little Green Pharma which provides up to 60% of the prescribed products has pulled out of the trial.
